MULTIPLE SHORT-COURSE TREATMENT OF BLINATUMOMAB CONSOLIDATION THERAPY REDUCES CUMULATIVE RELAPSE RATE IN B-ALL PATIENTS WITH DAY 19 BONE MARROW MRD ≥ 1.0*10-2 UNDER CCCG-ALL 2020 PROTOCOL

EHA Library, Chenyu Weng, 421088

USING ONLINE CONTINUING MEDICAL EDUCATION INITIATIVES TO IDENTIFY ONGOING GAPS IN CLINICIANS’ KNOWLEDGE, COMPETENCE, AND CONFIDENCE MANAGING ASPARAGINASE THERAPIES IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Sarah Elizabeth Bomba, 421089

INTRATHECAL RITUXIMAB PLUS DEXAMETHASONE IN TRIPLE THERAPY REFRACTORY SANCTUARY CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN B-CELL MALIGNANCIES

EHA Library, Maher Salamoon, 421090

INTRACELLULAR CD3 AS A T LINEAGE MARKER IN LEUKEMIA: ROLE OF INTENSITY

EHA Library, Jitka Stancikova, 421091

BLINATUMOMAB EXPERIENCE IN PEDIATRIC ALL TREATMENT: IS IT EFFECTIVE IN EXTRAMEDULLARY DISEASE?

EHA Library, Suleimen Zhumatayev, 421092

LENALIDOMIDE-ASSOCIATED B-ALL RESPONDS WELL TO CVAD AND ANTI-CD22 INOTUZUMAB: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Ximena Bruno, 421093

A PRELIMINARY STUDY ON THE SAFETY AND EFFICACY OF LOW-DOSE ORLOTINIB COMBINED WITH CHEMOTHERAPY IN NEWLY DIAGNOSED PH+ ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA

EHA Library, Yi Wang, 421094

PROGNOSTIC SIGNIFICANCE OF TP53 ALTERATIONS IN CHILDHOOD B-ALL

EHA Library, Yangyang Gao, 421095

FIXED DOSE OF INOTUZUMAB OZOGAMICIN COMBINED WITH VP-BASED CHEMOTHERAPY INDUCES EFFICACY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OF DIFFERENT STAGES INCLUDING MAINTENANCE

EHA Library, Sijie Tang, 421096

B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CLINICAL COURSE AND UNUSUAL CERVICAL RELAPSE

EHA Library, Nourhene Guedri, 421097

EFFICACY AND SAFETY OF BLINATUMOMAB BRIDGING THERAPY AFTER INDUCTION FOR NEWLY DIAGNOSED PEDIATRIC B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ruidong Zhang, 421098

CLONAL EVOLUTION DEFINES PROGNOSTIC STRATIFICATION FOR CENTRAL NERVOUS SYSTEM LEUKEMIA IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Jia Li, 421099

INOTUZUMAB OZOGAMICIN RESCUE TREATMENT IMPROVED THE SURVIVAL OF HIGH-RISK ADULT R/R B-ALL PATIENTS WITH CRITICAL TUMOR SUPPRESSOR GENE ALTERATION

EHA Library, Zihong Cai, 421100

A COMPARATIVE ANALYSIS OF CYTOGENETIC ABERRATIONS, MUTATION PROFILE AND POST INDUCTION MRD IN ETP AND NON ETP T- ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Sujeet Kumar, 421101

A COMBINED TYROSINE KINASE INHIBITOR AND BLINATUMOMAB APPROACH IN PHILADELPHIA CHROMOSOME-POSITIVE OR PHILADELPHIA CHROMOSOME-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Miao Miao, 421102

CLINICAL CHARACTERISTICS OF FIRST RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN, ADOLESCENT AND YOUNG ADULTS

EHA Library, Aicha Ben kahla, 421103

THE FIRST YEAR AFTER A NEW DIAGNOSIS OF PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA. TREATMENT STRATEGIES AND DISEASE PROGRESSION THROUGH ITALIAN ADMINISTRATIVE HEALTHCARE DATA

EHA Library, Immacolata Esposito, 421104

DAY 8 GOOD STEROID RESPONSE PREDICTS POST-INDUCTION NEGATIVE MRD STATUS IN PEDIATRIC & AYA ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED WITH ALL IC-BFM 2009 PROTOCOL: SINGLE-CENTER STUDY FROM INDIA

EHA Library, Adamya Gupta, 421105

REAL-WORLD OUTCOMES OF RELAPSED PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN PATIENTS TREATED UP FRONT WITH A PEDIATRIC-INSPIRED PROTOCOL

EHA Library, Maria Agustina Perusini, 421106

POST-INDUCTION MONOCYTE COUNT PREDICTS LONG TERM SURVIVAL IN YOUNG PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA / LYMPHOBLASTIC LYMPHOMA

EHA Library, Ana Vagos Mata, 421107

THERAPEUTIC RESULTS OF COOPRALL REGIEMEN IN FIRST RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Aicha Ben kahla, 421109

USE OF BLINATUMOMAB AS BRIDGE THERAPY BEFORE ALLOGENEIC BONE MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE B-LYMPHOBLASTIC LEUKEMIA (B-ALL)

EHA Library, Maryna Dubina, 421110

INCIDENCE OF VENOUS THROMBOEMBOLISM AND EFFECT IN MORTALITY IN PATIENTS NEWLY DIAGNOSED WITH PH- ALL TREATED WITH ASPARAGINASE: SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Miguel Navarro Sánchez, 421112

HIGH NEUTROPHIL COUNT AT INITIAL DIAGNOSIS PREDICTS POOR PROGNOSIS IN ADULT EARLY T-CELL PRECURSOR LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Jieping Lin, 421113

PROGNOSTIC IMPACT OF CONCURRENT GENETIC DELETIONS IN IKZF1 AND CDKN2 IN ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, So Yeon Park, 421115

PURINE-DERIVED PHENYLHYDROXAMATE INDUCES CELL DEATH IN AML CELLS

EHA Library, Jorge Carlos, 421116

UNIQUE EPIGENETIC PATTERNS OF DNA HYDROXYMETHYLATION (5HMC) IN AML: A NOVEL MICROARRAY TECHNOLOGY FOR 5HMC PROFILING IN PERIPHERAL BLOOD

EHA Library, Miriam Neaman, 421117

DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN ADULT ACUTE MYELOMONOCYTIC LEUKEMIA

EHA Library, Olena Zotova, 421118

SYNERGISTIC EFFECTS OF THE RARALPHA AGONIST TAMIBAROTENE AND THE MENIN INHIBITOR REVUMENIB IN ACUTE MYELOID LEUKEMIA CELLS WITH KMT2A REARRANGEMENT OR NPM1 MUTATION

EHA Library, Maximilian Fleischmann, 421119

A NEW HUMAN ACUTE MYELOID LEUKEMIA CELL LINE SDEY-AML1 WITH KMT2A-MLLT3, IKZF1-EVX1, P53, ETV6 GENE ALTERATIONS AND HIGH TUMORIGENICITY IN NSG MICE

EHA Library, Chenwei Yang, 421120

ABERRANT IMMUNOPHENOTYPIC PROFILES IN ACUTE MYELOID LEUKEMIA

EHA Library, Maha Charfi, 421121

EXPRESSION OF NON-CODING RNA DANCR AND ITS REGULATORY RIBOSOME-BINDING PROTEIN IN ACUTE MYELOID LEUKEMIA

EHA Library, Pi-Han Liao, 421122

MIR-342 GENE METHYLATION AND MUTATIONAL SIGNATURE OF THE ACUTE MYELOID LEUKEMIA

EHA Library, Tatyana Pospelova, 421123

THE DEPENDENCE OF ANEMIA ON THE CONCENTRATION OF CYTOKINES, TNF, TGFΒ1, IN THE ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Vira Barilka, 421124

EXPRESSION ANALYSIS, CLINICAL SIGNIFICANCE AND POTENTIAL FUNCTION OF ALOX5AP IN ACUTE MYELOID LEUKEMIA

EHA Library, HARSH GOEL, 421125

SINGLE-CELL TRANSCRIPTOME PROFILING OF M6A REGULATOR-MEDIATED METHYLATION MODIFICATION PATTERNS IN ELDERLY AML PATIENTS

EHA Library, Ruijuan Zhang, 421126

A PROSPECTIVE STUDY TO EVALUATE THE PROGNOSTIC IMPLICATIONS OF MMP-2 GENE IN ACUTE MYELOID LEUKEMIA

EHA Library, HARSH GOEL, 421127

THE THERAPEUTIC POTENTIAL OF THE EXON-JUNCTION COMPLEX RNA HELICASE EIF4A3 IN ACUTE MYELOID LEUKEMIA.

EHA Library, Dimitris Kanellis, 421128

THE IMPACT OF PATIENT SPECIFIC CARCINOGENIC EXPOSURES ON TP53 MUTATED MYELOID NEOPLASMS

EHA Library, Katie Liston, 421129

EXPLORING THE ACTIVITY OF VENETOCLAX IN PRIMARY AML CELLS BY MIMICKING THE TUMOR MICROENVIRONMENT.

EHA Library, Jenifer Sanchez, 421130

IMPORTANCE OF CYTOGENETICS IN IDENTIFICATION OF ATYPICAL MECOM GENE REARRANGEMENTS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Isabel Salazar, 421131

INHIBITION OF CDK4/6 AUGMENTS ATRA-INDUCED DIFFERENTIATION ACROSS ACUTE MYELOID LEUKAEMIA SUBTYPES

EHA Library, Rhiannon Newman, 421132

PRMT2 GOVERNS INFLAMMATION IN ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Denis Masnikov, 421133

KMT2A (MLL) GENE AMPLIFICATION IN ACUTE MYELOID LEUKEMIA, SERIE OF THREE CASES AND LITERATURE REVIEW.

EHA Library, María José López de la Osa Velacoracho, 421134

EFFECT AND MECHANISM OF HPK1 INHIBITOR BGB-15025 ON ACUTE MYELOID LEUKEMIA

EHA Library, Shiyu Yang, 421135

STABILITY ASSESSMENT OF FRESH OR CRYOPRESERVED WHOLE BLOOD AND BONE MARROW SAMPLES FROM AML PATIENTS TO MONITOR CD123 RECEPTOR AND IMMUNE CELLS SUBSETS

EHA Library, Maxime Moulard, 421137

CHROMOSOME 11 ABNORMALITIES IN ACUTE MYELOID LEUKEMIA

EHA Library, Ana Franjević, 421138

CYTOGENETIC ANALYSIS OF ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE CENTRE REPORT

EHA Library, Ana Franjević, 421139

SHENGMA BIEJIA DECOCTION PROMOTES APOPTOSIS OF LEUKEMIA CELLS BY DOWN-REGULATING MITOCHONDRIAL FUSION

EHA Library, Wenjian Wei, 421140

STUDY OF THE MOLECULAR GENETIC PROFILE OF HIGH-RISK AML PATIENTS USING NEXT GENERATION SEQUENCING

EHA Library, Ekaterina Motyko, 421141

ACTIVATION OF C-MYC CONTRIBUTES TO VENETOCLAX-RESISTANCE IN ACUTE MYELOID LEUKEMIA VIA INHIBITION OF THE TRANSCRIPTION OF BIM

EHA Library, Guopan YU, 421142

THE PATHOGENESIS ROLE OF TRANSFORMING GROWTH FACTOR Β1 IN ACUTE MYELOBLASTIC LEUKEMIA WITH MATURATION RELATED THROMBOCYTOPENIA

EHA Library, Vira Barilka, 421143

ACUTE MYELOID LEUKEMIA AND ACQUIRED FACTOR VII DEFICIENCY - A NOT-SO-RARE ALLIANCE IN CLINICAL REALITIES

EHA Library, Ahlem Slama, 421144

FLOW-CYTOMETRY CHARACTERIZATION OF LEUKEMIC STEM CELLS AS AN INNOVATIVE AND PERSONALIZED BIOMARKER OF PROGNOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: AN EXPLORATIVE STUDY

EHA Library, Paola Pacelli, 421145

PROSPECTIVE EVALUATION OF THROMBO-HEMORRHAGIC EVENTS AND TISSUE FACTOR EXPRESSION IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA RECEIVING ATRA-BASED INDUCTION THERAPY

EHA Library, Francesca Schieppati, 421146

MOLECULAR MEASURABLE RESIDUAL DISEASE DETECTION IN AML WITH MUTATED CEBPA

EHA Library, Emma Boertjes, 421148

DUAL TARGETING OF MCL-1 AND SPHINGOLIPID METABOLISM: CAN IT BE A NOVEL APPROACH FOR AN EFFECTIVE TREATMENT OF ACUTE MYELOID LEUKEMIA?

EHA Library, Melis Kartal Yandim, 421149

TUMOR MICROENVIRONMENT IN NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE ROLE OF MESENCHYMAL STEM CELLS

EHA Library, Ludovica Calabretta, 421150

INFLAMMATION AND COAGULATION PARAMETERS AS RISK FACTORS FOR DEVELOPMENT OF THROMBOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Emilija Zivkovic, 421151

PROGNOSTIC RELEVANCE OF VARIANT ALLELIC FREQUENCY FOR TREATMENT OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Rafael Colmenares, 421152

CD9 AS A PROGNOSTIC MARKER IN ACUTE MYELOID LEUKEMIA

EHA Library, sabrine khirallah, 421154

PROGNOSTIC ROLE OF CD81 IN ACUTE MYELOID LEUKEMIA

EHA Library, sabrine khirallah, 421155

NETWORK BASED STRATIFICATION HELPS REFINE STRATIFICATION OF INTERMEDIATE-RISK ACUTE MYELOID LEUKEMIA SAMPLES

EHA Library, Ankita Srivastava, 421156

DIFFERENCES IN IMMUNE TRANSCRIPTOMIC PROFILE ARE ASSOCIATED WITH RESPONSE TO AZACITIDINE AND VENETOCLAX IN NEWLY DIAGNOSED UNFIT-FOR-CHEMOTHERAPY ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Letizia Zannoni, 421157

A HIGH-THROUGHPUT DRUG SCREENING METHOD IDENTIFIES NOVEL, SYNERGISTIC DRUG COMBINATIONS WITH STATINS IN PAEDIATRIC AML

EHA Library, Evangeline Johnston, 421158

FREQUENT TRUNCATING MUTATIONS IN TET2 GENE AND GLOBAL DNA HYPERMETHYLATION CHARACTERIZES ACUTE MYELOID LEUKEMIA WITH ISOLATED TRISOMY 4

EHA Library, sayantanee Dutta, 421159

BCL11B REARRANGEMENT DEFINES A NEW PEDIATRIC ACUTE LEUKEMIA ENTITY

EHA Library, Valeria Ceolin, 421160

CYTOKINE AND CHEMOKINE PROFILING REVEALS DISTINCT SIGNATURES IN PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Stephanie Sendker, 421161

CO-MUTATION LANDSCAPE AND ITS PROGNOSTIC IMPACT ON NEWLY DIAGNOSED ADULT PATIENTS WITH NPM1 MUTATED DE NOVO ACUTE MYELOID LEUKEMIA

EHA Library, Yiyi Yao, 421162

GILTERITINIB CAUSES CELLULAR CHANGES INDEPENDENT OF FLT3 AND LEADING TO DRUG RESISTANCE IN AML

EHA Library, Martina Ceckova, 421163

CORE TARGETS INTERACTOMICS UNVEILED THE MECHANISM OF ACTION IN NOVEL DRUG COMBINATORIAL THERAPY OF AML

EHA Library, Ehsan Zangene, 421164

BCL2-TCL1 AS A PROPOSED NEW COMBINATION FOR THE DETERMINATION OF MEASURABLE RESIDUAL DISEASE BY FLOW CYTOMETRY IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, Angeliki Kotsiafti, 421165

EVALUATION OF NOVEL FLT3 INHIBITORS IN ACUTE MYELOID LEUKEMIA

EHA Library, Jan Rataj, 421166

GP6: A NOVEL HEMATOLOGIC MALIGNANCY PREDISPOSING GENE?

EHA Library, Cristina Natalucci, 421168

AML WITH PLASMACYTOID DENDRITIC CELL EXPANSION IN TWO CHILDREN WITH UNDERLYING CONGENITAL BONE MARROW FAILURE SYNDROME

EHA Library, Nina Friesgaard Øbro, 421169

THE RISK OF SECOND PRIMARY MALIGNANCY IN ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS TREATED WITH ARSENIC TRIOXIDE

EHA Library, Ming-Hsien Lin, 421170

CLINICAL CHARACTERISTICS AND OUTCOMES OF NUP98 REARRANGEMENT IN ADULTS WITH ACUTE LEUKEMIA

EHA Library, Katherine Klein, 421171

CLINICAL CHARACTERISTICS AND PROGNOSIS OF ACUTE MYELOID LEUKEMIA PATIENTS WITH RUNT-RELATED TRANSCRIPTION FACTOR 1 MUTATION: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Linya Wang, 421173

LEUKOCYTOSIS IN LOW-INTERMEDIATE RISK ACUTE PROMYELOCYTIC LEUKEMIA DURING ATRA-ATO INDUCTION THERAPY: A REAL-LIFE STUDY

EHA Library, Laura Cicconi, 421174

RELEVANCE OF DISCRIMINATION OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN) FROM RELATED HEMATOLOGIC MALIGNANCIES

EHA Library, Paolo Mazzeo, 421175

DOES MRD ASSESSMENT ALLOW FOR EARLY PREDICTION OF EXTRAMEDULLARY RELAPSE IN PATIENTS WITH MYELOID NEOPLASM AFTER ALLOGENEIC STEM CELL TRANSPLANTATION?

EHA Library, Jule Ussmann, 421176

PATIENT INVOLVEMENT IN THE TRIAL DESIGN OF ALIDHE: A PHASE 3B STUDY OF IVOSIDENIB + AZACITIDINE IN PATIENTS WITH NEWLY DIAGNOSED IDH1 MUTANT ACUTE MYELOID LEUKEMIA

EHA Library, Samantha Nier, 421177

PROGNOSTIC SIGNIFICANCE OF THE LEVEL OF C-REACTIVE PROTEIN AND IMMUNOPHENOTYPE IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY

EHA Library, Inga MANDAC ROGULJ, 421179

VENETOCLAX IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA AGED ≥60 YEARS: RESULTS FROM THE AML REAL WORLD EVIDENCE (ARC) INITIATIVE IN CHINA

EHA Library, Jianxiang Wang, 421180

REAL-WORLD ANTIEMETIC USE AND ITS ASSOCIATION WITH DURATION OF ORAL AZACITIDINE MAINTENANCE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN THE UNITED STATES

EHA Library, Thomas W LeBlanc, 421181

FEASIBILITY OF CONSECUTIVE DAY DOSING OF HIGH DOSE CYTARABINE VIA CONTINUOUS AMBULATORY DELIVERY DEVICE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, KYE LING WONG, 421182

LEVOFLOXACIN PREVENTS FEBRILE NEUTROPENIA DURING CYTARABINE CONSOLIDATION (IDAC/HIDAC) IN ACUTE MYELOID LEUKEMIA

EHA Library, Warangkana Assawawongsawat, 421183

THE IMPACT OF DELAYED HEMATOLOGICAL RECOVERY ON THE OUTCOME IN ACUTE MYELOID LEUKEMIA WITH NEGATIVE MINIMAL RESIDUAL DISEASE POST INDUCTION I IN CHILDREN

EHA Library, nissma shhain, 421184

CHARACTERIZATION OF ACUTE MYELOID LEUKAEMIA PATIENTS WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS, WITHIN A PORTUGUESE TERTIARY CARE HOSPITAL

EHA Library, André Pardal, 421186

FEASIBILITY OF POST-REMISSION ARA-C CONSOLIDATION IN PATIENTS WITH AML AFTER CPX-351 INDUCTION.

EHA Library, Salvatore Perrone, 421187

GENETIC, EPIGENETIC, AND CLINICAL SIGNIFICANCE OF WILMS’ TUMOR 1 (WT1) GENE IN ACUTE MYELOID LEUKEMIA

EHA Library, HARSH GOEL, 421188

PREVALENCE OF CT-DEFINED LOW MUSCLE QUANTITY AND QUALITY IN OLDER AML PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY: RESULTS FROM A MULTICENTER BRAZILIAN COHORT

EHA Library, Frederico Lisboa Nogueira, 421189

EFFICACY AND TOLERABILITY OF TREATMENT WITH VENETOCLAX AND AZACITIDINE FOR 5 DAYS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE.

EHA Library, Oriana Francesca Bianco, 421190

SAFETY OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING GEMTUZUMAB OZOGAMICIN AND PROCEEDING TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Partow Kebriaei, 421191

RISK-STRATIFIED TREATMENT OF SONROTOCLAX COMBINED WITH CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A MULTICENTER, PHASE II STUDY

EHA Library, Min Wu, 421192

REAL-WORLD TREATMENT OUTCOMES AND SAFETY OF REDUCED DOSE VENETOCLAX PLUS ANTIFUNGAL AGENTS FOR ACUTE MYELOID LEUKEMIA, A SINGLE HOSPITAL EXPERIENCE IN TAIWAN

EHA Library, Sheng-Yen Hsiao, 421193

THE CHARACTERS AND PROGNOSTIC ANALYSIS OF THERAPY-RELATED ACUTE MYELOID LEUKEMIA PATIENTS IN CHINA: A MULTICENTER STUDY

EHA Library, Feifei Tang, 421194

IMPROVING BONE MARROW MICROENVIRONMENT IN ACUTE MYELOGENOUS LEUKEMIA ELDERLY PATIENTS (AML) THROUGH 2 MONTHS OF PRE-INDUCTION WITH AZACITIDINE AND VENETOCLAX

EHA Library, Maher Salamoon, 421195

PRE-INDUCTION WITH FOUR WEEKLY HIGH-DOSE CYTARABINE, REDUCES MORTALITY RATE AND PROLONGS PROGRESSION FREE SURVIVAL IN ACUTE MYELOGENOUS LEUKEMIA (AML), A COMPARATIVE STUDY

EHA Library, Maher Salamoon, 421196

RELAPSE-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING POST-HEMATOPOIETIC STEM CELL TRANSPLANT MAINTENANCE THERAPY

EHA Library, Melinda Hamilton, 421197